Myeloid Immune Cells CARrying a New Weapon Against Cancer
Authors:
- Rodrigo Nalio RamosRRRodrigo Nalio Ramos
- Samuel Campanelli Freitas CoutoSCSamuel Campanelli Freitas Couto
- Theo Gremen M. OliveiraTOTheo Gremen M. Oliveira
- Paulo KlingerPKPaulo Klinger
- Tarcio Teodoro BragaTBTarcio Teodoro Braga
- Eduardo Magalhães RegoEREduardo Magalhães Rego
- José Alexandre M. BarbutoJBJosé Alexandre M. Barbuto
- Vanderson RochaVRVanderson Rocha
Open Access
- 10 December 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 784421
Abstract
Chimeric antigen receptor (CAR) engineering for T cells and natural killer cells (NK) are now under clinical evaluation for the treatment of hematologic cancers. Although encouraging clinical results have been reported for hematologic diseases, pre-clinical studies in solid tumors have failed to prove the same effectiveness. Thus, there is a growing interest of the scientific community to find other immune cell candidate to express CAR for the treatment of solid tumors and other diseases. Mononuclear phagocytes may be the most adapted group of cells with potential to overcome the dense barrier imposed by solid tumors. In addition, intrinsic features of these cells, such as migration, phagocytic capability, release of soluble factors and adaptive immunity activation, could be further explored along with gene therapy approaches. Here, we discuss the elements that constitute the tumor microenvironment, the features and advantages of these cell subtypes and the latest studies using CAR-myeloid immune cells in solid tumor models.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (442676/2020-4 308053/2017-6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 195 references indexed in Scilit:
- Origins of tumor-associated macrophages and neutrophilsProceedings of the National Academy of Sciences, 2012
- Leukocyte composition of human breast cancerProceedings of the National Academy of Sciences of the United States of America, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cellsJournal of Experimental Medicine, 2010
- Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensJournal of Experimental Medicine, 2010
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaNew England Journal of Medicine, 2010
- MicroRNA-155 is induced during the macrophage inflammatory responseProceedings of the National Academy of Sciences, 2007
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996